


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:05:35Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405087" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405087</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>aic</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="letter" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Intensive Care</journal-id><journal-id journal-id-type="iso-abbrev">Ann Intensive Care</journal-id><journal-id journal-id-type="pmc-domain-id">1590</journal-id><journal-id journal-id-type="pmc-domain">aic</journal-id><journal-title-group><journal-title>Annals of Intensive Care</journal-title></journal-title-group><issn pub-type="epub">2110-5820</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405087</article-id><article-id pub-id-type="pmcid-ver">PMC12405087.1</article-id><article-id pub-id-type="pmcaid">12405087</article-id><article-id pub-id-type="pmcaiid">12405087</article-id><article-id pub-id-type="pmid">40897952</article-id><article-id pub-id-type="doi">10.1186/s13613-025-01544-x</article-id><article-id pub-id-type="publisher-id">1544</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Reconsidering early RRT in leptospirosis AKI: a question of timing criteria</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="PC">Pei-Chen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9387-0798</contrib-id><name name-style="western"><surname>Huang</surname><given-names initials="TTM">Thomas Tao-Min</given-names></name><address><email>taomin.huang@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/015b6az38</institution-id><institution-id institution-id-type="GRID">grid.413593.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0573 007X</institution-id><institution>Division of Nephrology, Department of Internal Medicine, </institution><institution>MacKay Memorial Hospital, </institution></institution-wrap>Taipei City, Taiwan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00t89kj24</institution-id><institution-id institution-id-type="GRID">grid.452449.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1762 5613</institution-id><institution>Department of Medicine, </institution><institution>MacKay Medical College, </institution></institution-wrap>New Taipei City, Taiwan </aff><aff id="Aff3"><label>3</label>Taiwan Society of Emergency and Critical Care Medicine, Taipei City, Taiwan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03nteze27</institution-id><institution-id institution-id-type="GRID">grid.412094.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0572 7815</institution-id><institution>Department of Internal Medicine (Nephrology and Critical Care), </institution><institution>National Taiwan University Hospital and College of Medicine, </institution></institution-wrap>No. 7, Chung Shan S. Rd., Zhong-Zheng District, Taipei City, 10008 Taiwan </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478464</issue-id><elocation-id>132</elocation-id><history><date date-type="received"><day>18</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>12</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 03:25:41.473"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="13613_2025_Article_1544.pdf"/><related-article related-article-type="commentary-article" xml:lang="en" xlink:title="research-article" journal-id="Ann Intensive Care" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC12078916"><article-title>Immediate or delayed initiation of renal replacement therapy in patients with leptospirosis and acute kidney injury: a target trial emulation</article-title><volume>15</volume><date><day>14</day><month>5</month><year>2025</year></date><elocation-id>65</elocation-id><source>Annals of Intensive Care</source><pub-id pub-id-type="doi">10.1186/s13613-025-01477-5</pub-id><pub-id pub-id-type="pmcid">PMC12078916</pub-id><pub-id pub-id-type="pmid">40369328</pub-id></related-article><funding-group><award-group><funding-source><institution>Taiwan Health Foundation</institution></funding-source><award-id>Taiwan Health Foundation</award-id><principal-award-recipient><name name-style="western"><surname>Huang</surname><given-names>Thomas Tao-Min</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; La Soci&#233;t&#233; de R&#233;animation de Langue Francaise = The French Society of Intensive Care (SRLF) 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">Dear Editor-in-Chief,</p><p id="Par2">We read with great interest the recent article by Julien et al. investigating the timing of renal replacement therapy (RRT) in patients with leptospirosis-associated acute kidney injury, AKI-L) [<xref ref-type="bibr" rid="CR1">1</xref>]. The authors should be commended for addressing this clinically relevant question through an emulated target trial design, one that is especially valuable given the logistical constraints of conducting randomized controlled trials in this context.</p><p id="Par3">However, we propose an alternative interpretation of the findings: the observed adverse outcomes in the early RRT group may not be inherent to early dialysis initiation per se, but rather reflect a fundamental limitation in using KDIGO Stage 3 as a surrogate trigger for RRT initiation in leptospirosis.</p><p id="Par4">The authors define &#8220;early RRT&#8221; as initiation within 48&#160;h of hospital admission among patients with KDIGO Stage 3 AKI. Yet AKI-L exhibits distinct pathophysiological and clinical profiles, including preserved urine output, hypokalemia, and tubular sodium loss&#8212;factors which typically delay the onset of conventional RRT indications. Indeed, in the manuscript, the authors note that 64% of patients in the early RRT group did not exhibit hyperkalemia, BUN&#8201;&gt;&#8201;30 mmol/L, or severe metabolic acidosis at the time of RRT initiation. This suggests a sizeable portion of RRTs may have been initiated preemptively based on creatinine rise alone [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par5">The increased incidence of new-onset or worsening CKD in the early group (OR 2.74, <italic toggle="yes">p</italic>&#8201;=&#8201;0.012) raises the possibility that premature initiation of RRT&#8212;when not clinically indicated&#8212;may contribute to downstream harm, perhaps via hemodynamic instability or sustained RRT-dependence [<xref ref-type="bibr" rid="CR1">1</xref>]. Rather than undermining early RRT altogether, these findings argue against the validity of applying KDIGO Stage 3 as a one-size-fits-all threshold in AKI-L.</p><p id="Par6">This interpretation is supported by major randomized controlled trials in broader AKI populations, such as AKIKI [<xref ref-type="bibr" rid="CR2">2</xref>], IDEAL-ICU [<xref ref-type="bibr" rid="CR3">3</xref>], STARRT-AKI [<xref ref-type="bibr" rid="CR4">4</xref>], and ELAIN [<xref ref-type="bibr" rid="CR5">5</xref>]. While the ELAIN trial did show a benefit of early RRT initiation in a highly selected population using a biomarker-guided strategy, it also emphasized the importance of individualized patient selection and timely initiation guided by both functional and biochemical markers [<xref ref-type="bibr" rid="CR5">5</xref>]. Together, these studies underscore that early RRT may be beneficial only when guided by robust, patient-specific criteria&#8212;not staging alone [<xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par7">Julien et al.&#8216;s own findings further strengthen this argument. Of the patients in the early RRT group, a majority did not have any classical dialysis indications at the time of RRT initiation. Additionally, the delayed group revealed that 75% of patients ultimately avoided RRT altogether and yet achieved favorable renal outcomes, indicating that Stage 3 AKI alone may not reliably identify patients who truly require RRT [<xref ref-type="bibr" rid="CR1">1</xref>]. Furthermore, AKI-L often progresses in a biphasic manner and may be reversible with supportive therapy, suggesting that relying on staging thresholds such as KDIGO Stage 3 risks unnecessary initiation of RRT, with potential long-term iatrogenic harm (e.g., HIRRT and dialysis dependency).</p><p id="Par8">In conclusion, this study reinforces the need to move beyond creatinine-centric definitions of &#8220;early&#8221; RRT in leptospirosis. We advocate for research efforts that refine patient selection criteria, with particular attention to the unique trajectory of AKI-L. Such efforts may better identify those truly likely to benefit from RRT while sparing others from unnecessary intervention.</p></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This manuscript is founded by Taiwan Health Foundation.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>PCW conducted literature review, and drafted the manuscript. TTMH conceived the viewpoint, conducted literature review, and drafted the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>No funding was received for this work.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Not applicable.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par9">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par10">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par11">The author declares that there are no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>AKI</term><def><p id="Par12">Acute kidney injury</p></def></def-item><def-item><term>AKI-L</term><def><p id="Par13">Leptospirosis-associated acute kidney injury</p></def></def-item><def-item><term>CKD</term><def><p id="Par14">Chronic kidney disease</p></def></def-item><def-item><term>KDIGO</term><def><p id="Par15">Kidney Disease Improving Global Outcomes</p></def></def-item><def-item><term>RRT</term><def><p id="Par16">Renal replacement therapy</p></def></def-item><def-item><term>HIRRT</term><def><p id="Par17">Hemodynamic instability-related renal replacement therapy</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Julien</surname><given-names>M</given-names></name><name name-style="western"><surname>Rafat</surname><given-names>C</given-names></name><name name-style="western"><surname>Raffray</surname><given-names>L</given-names></name><etal/></person-group><article-title>Immediate or delayed initiation of renal replacement therapy in patients with leptospirosis and acute kidney injury: a target trial emulation</article-title><source>Ann Intensive Care</source><year>2025</year><volume>15</volume><fpage>65</fpage><pub-id pub-id-type="pmid">40369328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13613-025-01477-5</pub-id><pub-id pub-id-type="pmcid">PMC12078916</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Julien M, Rafat C, Raffray L, et al. Immediate or delayed initiation of renal replacement therapy in patients with leptospirosis and acute kidney injury: a target trial emulation. Ann Intensive Care. 2025;15:65.<pub-id pub-id-type="pmid">40369328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13613-025-01477-5</pub-id><pub-id pub-id-type="pmcid">PMC12078916</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaudry</surname><given-names>S</given-names></name><name name-style="western"><surname>Hajage</surname><given-names>D</given-names></name><name name-style="western"><surname>Schortgen</surname><given-names>F</given-names></name><etal/></person-group><article-title>Initiation strategies for renal-replacement therapy in the intensive care unit</article-title><source>N Engl J Med</source><year>2016</year><volume>375</volume><fpage>122</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">27181456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1603017</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375:122&#8211;33.<pub-id pub-id-type="pmid">27181456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1603017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barbar</surname><given-names>SD</given-names></name><name name-style="western"><surname>Clere-Jehl</surname><given-names>R</given-names></name><name name-style="western"><surname>Bourredjem</surname><given-names>A</given-names></name><etal/></person-group><article-title>Timing of renal-replacement therapy in patients with acute kidney injury and sepsis</article-title><source>N Engl J Med</source><year>2018</year><volume>379</volume><fpage>1431</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">30304656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1803213</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379:1431&#8211;42.<pub-id pub-id-type="pmid">30304656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1803213</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><collab>STARRT-AKI Investigators</collab></person-group><article-title>Timing of initiation of renal-replacement therapy in acute kidney injury</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><fpage>240</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">32668114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa2000741</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">STARRT-AKI Investigators. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383:240&#8211;51.<pub-id pub-id-type="pmid">32668114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa2000741</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zarbock</surname><given-names>A</given-names></name><name name-style="western"><surname>Kellum</surname><given-names>JA</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial</article-title><source>JAMA</source><year>2016</year><volume>315</volume><issue>20</issue><fpage>2190</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">27209269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.5828</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315(20):2190&#8211;9.<pub-id pub-id-type="pmid">27209269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.5828</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>